Osteopontin regulates interleukin-17 production in hepatitis
Osteopontin regulates interleukin-17 production in hepatitis
复制标题
DOI:
10.1016/j.cyto.2012.06.287
复制
发表时间:
2012-10-01
期刊:
影响因子:
3.8
通讯作者:
Li, Lanjuan
中科院分区:
文献类型:
--
作者:
Diao, Hongyan;Liu, Xiangdong;Li, Lanjuan
The overexpression of osteopontin is associated with various inflammatory liver diseases. Interestingly, each of these diseases is also associated with IL-17 expression. Therefore, we sought to determine whether there is any mechanistic link between osteopontin and IL-17. Herein we show that IL-17 and osteopontin levels were significantly increased in patients with chronic hepatitis B. We found that IL-17 and osteopontin levels increased similarly in mice with concanavalin A-induced hepatitis. Both osteopontin- and IL-17-deficient mice were resistant to concanavalin A-induced hepatic injury. In addition, osteopontin markedly induced IL-17 expression by leukocytes (from humans and mice). This effect could be blocked by a specific antibody against osteopontin. 03 integrin (one of the osteopontin receptors) was critically involved in the induction of IL-17 production by osteopontin. Osteopontin-induced IL-17 expression was mediated through the p38. JNK, and NF-kappa B pathways. These findings suggest that osteopontin regulates IL-17 production during the pathogenesis of hepatitis and provide new evidence for the critical roles of osteopontin and IL-17 in hepatitis. (C) 2012 Elsevier Ltd. All rights reserved.